Psychiatry & Neurology Doctors in South Weumouth, MA Accepting Medicare
1 Psychiatry & Neurology doctors found. Showing 1 - 1
 Dr. Swapna Lakshmi Putta, M.D Psychiatry & Neurology - Clinical Neurophysiology Medicare: Accepting Medicare Assignments Practice Location: 55 Fogg Road, Bwh Department Of Neurology, Emerson 150, South Weumouth, MA 02190 Phone: 781-624-8197 Fax: 781-624-6735 |
News Archive
Office of Naval Research harnessing human brain power to control the maneuvers of UUVs
Even the least graceful among us has motor control the most high-tech unmanned undersea vehicle would envy, thanks to a region of the brain that allows our bodies to carry out complex maneuvers. The Office of Naval Research, which traditionally relies on the power of the human mind to achieve breakthroughs in science and technology, now also is harnessing the working principle of the brain to control the maneuvers of UUVs.
Researchers develop bioactive coating that actively suppresses brain's immune response
Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.
Study delineates the dynamic MAIT cell response during acute HIV infection
In a new study published in Nature Communications, researchers at Karolinska Institutet show that MAIT cells (mucosa-associated invariant T cells), part of the human immune system, respond with dynamic activity and reprogramming of gene expression during the initial phase of HIV infection.
immatics, Roche enter into cancer vaccine and immunotherapy deal
immatics biotechnologies GmbH and Roche today announced a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics.
Genentech receives FDA Refuse to File letter for accelerated approval of trastuzumab-DM1 BLA
ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that Genentech, a member of the Roche Group, today announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010.
› Verified 8 days ago